Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOslo University Hospital
About this trial
The aim of this study is to identify biomarkers of disease recurrence and prognosis to optimize patient selection for treatment with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), and through animal models to explore different treatment strategies for peritoneal surface malignancies (PSM).
Eligibility criteria
Qualifiers
age > 18 years
confirmed diagnosis of peritoneal surface malignancy
candidate for CRS-HIPEC
written informed consent
Disqualifiers
none
Trial design
Treatments tested in this trial
- Observational study.
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Oslo University Hospital
Lead sponsor
The Research Council of Norway
Collaborator
Source ClinicalTrials.gov